308 related articles for article (PubMed ID: 17620757)
21. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
22. Involving new actors to achieve ART scaling-up: difficulties in an HIV/AIDS counselling and testing centre in Cameroon.
Yakam JC; Gruénais ME
Int Nurs Rev; 2009 Mar; 56(1):50-7. PubMed ID: 19239516
[TBL] [Abstract][Full Text] [Related]
23. Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance.
Parekh BS; Kalou MB; Alemnji G; Ou CY; Gershy-Damet GM; Nkengasong JN
Am J Clin Pathol; 2010 Oct; 134(4):573-84. PubMed ID: 20855638
[TBL] [Abstract][Full Text] [Related]
24. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
25. Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa.
Taiwo BO; Murphy RL
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S11-8. PubMed ID: 18061953
[TBL] [Abstract][Full Text] [Related]
26. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS.
Glencross DK; Janossy G; Coetzee LM; Lawrie D; Aggett HM; Scott LE; Sanne I; McIntyre JA; Stevens W
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S40-51. PubMed ID: 18228554
[TBL] [Abstract][Full Text] [Related]
27. [HIV-test policy for tuberculosis patients in the Netherlands].
Haar CH; Cobelens FG; Kalisvaart NA; van der Have JJ; van Deutekom H
Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2674-9. PubMed ID: 18179086
[TBL] [Abstract][Full Text] [Related]
28. [Mycobacterial tests].
Takashima T; Higuchi T
Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
[TBL] [Abstract][Full Text] [Related]
29. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
Quentin W; König HH; Schmidt JO; Kalk A
Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
[TBL] [Abstract][Full Text] [Related]
30. [AIDS treatment in Africa: the risk of antiretroviral resistance].
Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
[TBL] [Abstract][Full Text] [Related]
31. Decentralization of CD4 testing in resource-limited settings: 7 years of experience in six African countries.
Marinucci F; Medina-Moreno S; Paterniti AD; Wattleworth M; Redfield RR
Cytometry A; 2011 May; 79(5):368-74. PubMed ID: 21495181
[TBL] [Abstract][Full Text] [Related]
32. Barriers to access to antiretroviral treatment in developing countries: a review.
Posse M; Meheus F; van Asten H; van der Ven A; Baltussen R
Trop Med Int Health; 2008 Jul; 13(7):904-13. PubMed ID: 18466183
[TBL] [Abstract][Full Text] [Related]
33. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
[TBL] [Abstract][Full Text] [Related]
34. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
Assefa Y; Kloos H
Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
[TBL] [Abstract][Full Text] [Related]
35. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
[TBL] [Abstract][Full Text] [Related]
36. 'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa.
Ventelou B; Moatti JP; Videau Y; Kazatchkine M
AIDS; 2008 Jan; 22(1):107-13. PubMed ID: 18090398
[TBL] [Abstract][Full Text] [Related]
37. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
[TBL] [Abstract][Full Text] [Related]
38. Funding shortages challenge AIDS drug assistance program.
Engle L
Body Posit; 1998 Aug; 11(8):12. PubMed ID: 11365693
[TBL] [Abstract][Full Text] [Related]
39. The (political) economics of antiretroviral treatment in developing countries.
Nattrass NJ
Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
[TBL] [Abstract][Full Text] [Related]
40. Promoting child and adolescent mental health in the context of the HIV/AIDS pandemic with a focus on sub-Saharan Africa.
Earls F; Raviola GJ; Carlson M
J Child Psychol Psychiatry; 2008 Mar; 49(3):295-312. PubMed ID: 18221344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
